Company: PMVP
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030414
Chunk: 193

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 1B
Chunk 193
---
 by reference.

Item 12.    Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The information required by this item will be included under the captions “Beneficial Ownership of Shares of Common Stock” and “Executive Compensation—Equity Compensation Plan Information” in the Proxy Statement and is incorporated herein by reference.

Item 13.    Certain Relationships and Related Transactions, and Director Independence.

The information required by this item will be included under the captions “Certain Relationships and Related Person Transactions” and “Directors and Corporate Governance” in the Proxy Statement and is incorporated herein by reference.

Item 14.    Principal Accounting Fees and Services.

The information required by this item will be included under the captions “Ratification of Appointment of Independent Registered Public Accounting Firm” in the Proxy Statement and is incorporated herein by reference.

 126

PART IV 

Item 15.    Exhibits and Financial Statement Schedules. 

EXHIBIT INDEX

    ExhibitNumber
      
    Description
     
    Form
     
    File No.
     
    Number
     
    Filing Date

      3.1
      
    Amended and Restated Certificate of Incorporation of the Registrant, as amended, as currently in effect.
     
    8-K
     
    001-39539
     
    3.1
     
    September 29, 2020

      3.2
      
    Amended and Restated Bylaws of the Registrant, as currently in effect.
     
    10-Q
     
    001-39539
     
    3.3
     
    May 10, 2023

      4.1
      
    Description of Securities of the Registrant. 
     
    10-K
     
    001-39539
     
    4.1
     
    March 3, 2021

      4.2
     
    Specimen common stock certificate of the Registrant.
     
    S-1/A
     
    333-248627
     
    4.2
     
    September 21, 2020

      4.3
     
    Form of Indenture.
     
    S-3
     
    333-283349
     
    4.5
     
    November 20, 2024

    10.